Aimei Health Technology Stock Today
| AFJK Stock | 11.00 0.01 0.09% |
PerformanceGood
| Odds Of DistressLow
|
Aimei Health is selling for 11.00 as of the 22nd of March 2025. This is a 0.09 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 11.0. Aimei Health has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 22nd of January 2024 | Category Financial Services | Classification Health Care |
Aimei Health is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 6.12 M outstanding shares of which 34 shares are presently shorted by private and institutional investors with about 0.0 trading days to cover. More on Aimei Health Technology
Moving together with Aimei Stock
Moving against Aimei Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Aimei Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
Aimei Health Technology (AFJK) is traded on NASDAQ Exchange in USA. It is located in 10 East 53rd Street, New York, NY, United States, 10022 and employs 2 people. Aimei Health is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 67.32 M. Aimei Health Technology conducts business under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 6.12 M outstanding shares of which 34 shares are presently shorted by private and institutional investors with about 0.0 trading days to cover.
Check Aimei Health Probability Of Bankruptcy
Ownership AllocationOver half of Aimei Health's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions.
Check Aimei Ownership Details
Aimei Health Historical Income Statement
Aimei Stock Against Markets
Already Invested in Aimei Health Technology?
The danger of trading Aimei Health Technology is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aimei Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aimei Health. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aimei Health Technology is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aimei Health Technology is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Aimei Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Aimei Health Technology Stock. Highlighted below are key reports to facilitate an investment decision about Aimei Health Technology Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aimei Health Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aimei Health. If investors know Aimei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aimei Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aimei Health Technology is measured differently than its book value, which is the value of Aimei that is recorded on the company's balance sheet. Investors also form their own opinion of Aimei Health's value that differs from its market value or its book value, called intrinsic value, which is Aimei Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aimei Health's market value can be influenced by many factors that don't directly affect Aimei Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aimei Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aimei Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aimei Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.